These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 26897090

  • 1. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X, Bao G, Wang L, Cheng M, Zhao M, Zhao S, Zhou H, Gong P.
    Bioorg Med Chem; 2016 Mar 15; 24(6):1331-45. PubMed ID: 26897090
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazone scaffolds as selective c-Met inhibitors.
    Qi B, Tao H, Wu D, Bai J, Shi Y, Gong P.
    Arch Pharm (Weinheim); 2013 Aug 15; 346(8):596-609. PubMed ID: 23843304
    [Abstract] [Full Text] [Related]

  • 3. Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors.
    Qi B, Mi B, Zhai X, Xu Z, Zhang X, Tian Z, Gong P.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5246-60. PubMed ID: 23838381
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors.
    Liu Z, Wang R, Guo R, Hu J, Li R, Zhao Y, Gong P.
    Bioorg Med Chem; 2014 Jul 15; 22(14):3642-53. PubMed ID: 24882675
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
    Tang Q, Zhao Y, Du X, Chong L, Gong P, Guo C.
    Eur J Med Chem; 2013 Nov 15; 69():77-89. PubMed ID: 24012712
    [Abstract] [Full Text] [Related]

  • 6. Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors.
    Liu M, Hou Y, Yin W, Zhou S, Qian P, Guo Z, Xu L, Zhao Y.
    Eur J Med Chem; 2016 Aug 25; 119():96-108. PubMed ID: 27155466
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors.
    Liu J, Yang D, Yang X, Nie M, Wu G, Wang Z, Li W, Liu Y, Gong P.
    Bioorg Med Chem; 2017 Aug 15; 25(16):4475-4486. PubMed ID: 28716639
    [Abstract] [Full Text] [Related]

  • 8. Design and Synthesis of Novel 4-Phenoxyquinolines Bearing 3-Hydrosulfonylacrylamido or 1H-Imidazole-4-carboxamido Scaffolds as c-Met Kinase Inhibitors.
    Wang J, Xie L, Wang Y, Wang X, Xi S, Zeng T, Gong P, Zhai X.
    Arch Pharm (Weinheim); 2017 Feb 15; 350(2):. PubMed ID: 28133784
    [Abstract] [Full Text] [Related]

  • 9. Design, Synthesis, and Biological Evaluation of 4-Phenoxyquinoline Derivatives Containing Benzo[d]thiazole-2-yl Urea as c-Met Kinase Inhibitors.
    Lei H, Hu G, Wang Y, Han P, Liu Z, Zhao Y, Gong P.
    Arch Pharm (Weinheim); 2016 Aug 15; 349(8):651-61. PubMed ID: 27283017
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors.
    Li J, Li J, Zhang J, Shi J, Ding S, Liu Y, Chen Y, Liu J.
    Anticancer Agents Med Chem; 2020 Aug 15; 20(5):559-570. PubMed ID: 31893997
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and pharmacological evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
    Zhou S, Ren J, Liu M, Ren L, Liu Y, Gong P.
    Bioorg Chem; 2014 Dec 15; 57():30-42. PubMed ID: 25173590
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
    Li S, Zhao Y, Wang K, Gao Y, Han J, Cui B, Gong P.
    Bioorg Med Chem; 2013 Jun 01; 21(11):2843-55. PubMed ID: 23628470
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors.
    Wang X, Jiang N, Zhao S, Xi S, Wang J, Jing T, Zhang W, Guo M, Gong P, Zhai X.
    Bioorg Med Chem; 2017 Feb 01; 25(3):886-896. PubMed ID: 28011202
    [Abstract] [Full Text] [Related]

  • 14. Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors.
    Tang Q, Zhang G, Du X, Zhu W, Li R, Lin H, Li P, Cheng M, Gong P, Zhao Y.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1236-49. PubMed ID: 24485123
    [Abstract] [Full Text] [Related]

  • 15. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.
    Nan X, Li HJ, Fang SB, Li QY, Wu YC.
    Eur J Med Chem; 2020 May 01; 193():112241. PubMed ID: 32200199
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agent.
    Wang Y, Ai J, Wang Y, Chen Y, Wang L, Liu G, Geng M, Zhang A.
    J Med Chem; 2011 Apr 14; 54(7):2127-42. PubMed ID: 21405128
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and antitumor activity of novel 4-(2-fluorophenoxy)quinoline derivatives bearing the 4-oxo-1,4-dihydroquinoline-3-carboxamide moiety.
    Li S, Jiang R, Qin M, Liu H, Zhang G, Gong P.
    Arch Pharm (Weinheim); 2013 Jul 14; 346(7):521-33. PubMed ID: 23776085
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.